Prosecution Insights
Last updated: October 04, 2026
Application No. 18/998,335

Method for Preparing Fiber Deodorant Composition

Non-Final OA §102§103§112
Filed
Mar 10, 2025
Priority
Aug 01, 2022 — RE 10-2022-0095372 +1 more
Examiner
WAX, ROBERT A
Art Unit
1615
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Bioworks
OA Round
1 (Non-Final)
25%
Grant Probability
At Risk
1-2
OA Rounds
2y 3m
Est. Remaining
29%
With Interview

Examiner Intelligence

Grants only 25% of cases
25%
Career Allowance Rate
27 granted / 108 resolved
-35.0% vs TC avg
Minimal +4% lift
Without
With
+3.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
59 currently pending
Career history
116
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
46.8%
+6.8% vs TC avg
§102
16.0%
-24.0% vs TC avg
§112
22.4%
-17.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 108 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Summary Claims 1-4 are pending in this office action. All pending claims are under examination in this application. Priority The current application filed on March 10, 2025 is a 371 of PCT/KR2023/009913 filed July 12, 2023, which in turn claims priority to Korean patent application KR10-2022-0095372 filed on August 21, 2022. Information Disclosure Statement Receipt of the Information Disclosure Statements filed on January 24, 2025 and March 10, 2025 is acknowledged. A signed copy of each form PTO/SB/08 is attached to this office action. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 3 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. This claim, as well as the specification, mentions “glycerin of 25ºC to 45 ºC” which is not understood. Obviously, some properties of glycerin are temperature-dependent such as viscosity, but the claim seems to be stating that glycerin at one temperature is different from glycerin at some other temperature. In addition to the above, the reason for which said glycerin of 25ºC to 45 ºC does not have any patentable weight. This claim is being examined as if it had no patentable weight. Claim Rejections - 35 USC § 102/103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-3 are rejected under 35 U.S.C. 102(a)(1) as anticipated by or, in the alternative, under 35 U.S.C. 103 as obvious over Shao et al., CN 108114588 A, published 2018-06-05, Reference D1 on the 237 with evidence provided by Li, CN 102329702 A, published January 25, 2012. Shao et al. teach deodorizing compositions comprising 0.5-60% citrus extract such as grapefruit extract, 5-50% polyol such as glycerin and water, see claims 1-4, 6 and 7. They do not teach that the glycerin is from palm oil. The claims are anticipated because the reference broadly teaches glycerin which includes glycerin from any source. Alternatively, should the source of the glycerin matter, it would have been obvious to one of ordinary skill in the art, prior to the instant effective filing date, to use glycerin from palm oil since such is known for use in cosmetics as taught by Li in paragraph [0012]. Allowable Subject Matter Claim 4 is objected to as being dependent upon a rejected base claim but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. While Kobayashi teaches the use of acerola fruit extract in deodorizing compositions and citric acid is already present from the grapefruit in Shao et al. examiner is unable to find motivation to add the acetic acid that is claimed. Conclusion No claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Robert A. Wax whose telephone number is (571)272-0623. The examiner can normally be reached 8:00 AM -4:00 PM Monday - Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Michener can be reached at (571) 272-1424. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Robert A Wax/Supervisory Patent Examiner, Art Unit 1615
Read full office action

Prosecution Timeline

Mar 10, 2025
Application Filed
Sep 16, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12728147
COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASE COMPRISING HYDROLYSIS EXTRACT OF PULSATILLA KOREANA AND ANEMONE RADDEANA AS ACTIVE INGREDIENT
3y 9m to grant Granted Sep 08, 2026
Patent 12728084
COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND A GAMMA-BUTYROLACTONE AND/OR A GAMMA-BUTYROLACTAM
2y 4m to grant Granted Sep 08, 2026
Patent 12708597
HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION
3y 2m to grant Granted Aug 18, 2026
Patent 12693288
QUALITY CONTROL SUBSTANCE FOR USE IN THE ANALYSIS OF ERYTHROCYTES
2y 10m to grant Granted Jul 28, 2026
Patent 12667539
ORAL GUM COMPOSITION
3y 9m to grant Granted Jun 30, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
25%
Grant Probability
29%
With Interview (+3.9%)
3y 10m (~2y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 108 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month